Platelet-activating factor podoplanin: from discovery to drug development
2017 · Cancer and Metastasis Reviews · 80 citations
https://doi.org/10.1007/s10555-017-9672-2
K
Kenichi Miyata
Meiji University(JP)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
10
Papers
78
Citations
6
h-index
5
i10-index
Kenichi Miyata is an academic researcher from Meiji University. The author has contributed to research in topics: Drug Transport and Resistance Mechanisms & Chemical Synthesis and Analysis & Innovation and Knowledge Management. The author has an h-index of 6, co-authored 9 publications.
ORCID: 0000-0002-4588-1134Papers by this author
worksHepatocyte growth factor derived from senescent cells attenuates cell competition-induced apical elimination of oncogenic cells
2022 · Nature Communications · 30 citations
https://doi.org/10.1038/s41467-022-31642-4
DNA/RNA heteroduplex technology with cationic oligopeptide reduces class-related adverse effects of nucleic acid drugs
2024 · Molecular Therapy — Nucleic Acids · 2 citations
https://doi.org/10.1016/j.omtn.2024.102289
Supplementary Table S5 from Targeting DHX9 Triggers Tumor-Intrinsic Interferon Response and Replication Stress in Small Cell Lung Cancer
2024 · 0 citations
https://doi.org/10.1158/2159-8290.25324696
Supplementary Figure S7 from Targeting DHX9 Triggers Tumor-Intrinsic Interferon Response and Replication Stress in Small Cell Lung Cancer
2024 · 0 citations
https://doi.org/10.1158/2159-8290.25324711
Supplementary Figure S3 from Targeting DHX9 Triggers Tumor-Intrinsic Interferon Response and Replication Stress in Small Cell Lung Cancer
2024 · 0 citations
https://doi.org/10.1158/2159-8290.25324726
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat